PRESS RELEASE published on 10/23/2024 at 18:00, 1 year 10 months ago BIOSYNEX SA: CHEMBIO DIAGNOSTICS INC, FILIALE DE BIOSYNEX, REÇOIT UNE SUBVENTION POUR LE DEVELOPPEMENT D'UN TEST DPP POUR LA SYPHILIS CONGENITALE BIOSYNEX SA: Chembio Diagnostics Inc, filiale de BIOSYNEX, reçoit une subvention pour le développement d'un test DPP pour la syphilis congénitale. La Bill & Melinda Gates Foundation finance un test rapide au chevet du patient Subvention BIOSYNEX SA Syphilis Congénitale Chembio Diagnostics Inc Test DPP
PRESS RELEASE published on 10/23/2024 at 18:00, 1 year 10 months ago BIOSYNEX SA: CHEMBIO DIAGNOSTICS INC., A SUBSIDIARY OF BIOSYNEX, RECEIVES A GRANT FOR DEVELOPMENT OF A DPP CONGENITAL SYPHILIS ASSAY Chembio Diagnostics Inc., a subsidiary of BIOSYNEX, receives a grant to develop a rapid point-of-care diagnostic test for congenital syphilis supported by the Bill & Melinda Gates Foundation Grant BIOSYNEX Congenital Syphilis Chembio Diagnostics Inc. Bill & Melinda Gates Foundation
PRESS RELEASE published on 10/23/2024 at 18:00, 1 year 10 months ago Konkur announces the completion of a conditional agreement for the sale of all its shares held in AgroGeneration Konkur Investments Limited agrees to sell 56.9% of AgroGeneration shares to Ukrainian company NOVAAGRO. All conditions met for the completion of the transaction Transaction AgroGeneration NOVAAGRO Konkur Investments Ukrainian Company
PRESS RELEASE published on 10/23/2024 at 18:00, 1 year 10 months ago THERANEXUS PUBLIE SA POSITION DE TRÉSORERIE AU 30 SEPTEMBRE 2024 Theranexus annonce sa trésorerie au 30 septembre 2024 avec 1,9 M€ disponible, incluant le Crédit Impôt Recherche de 785 K€. Projet d'enregistrement en Europe et phase 3 dans la maladie de Batten Trésorerie Phase 3 Theranexus Maladies Neurologiques CIR
PRESS RELEASE published on 10/23/2024 at 18:00, 1 year 10 months ago THERANEXUS ANNOUNCES ITS CASH POSITION AS OF SEPTEMBER 30, 2024 Theranexus reports €1.9 million cash position as of September 30, 2024, with plans for product registrations and phase 3 trials in rare neurological diseases Cash Position Biopharmaceutical Theranexus Rare Neurological Diseases Product Registrations
PRESS RELEASE published on 10/23/2024 at 18:00, 1 year 10 months ago Toosla poursuit l'enrichissement de sa plateforme nationale avec la signature d'un nouveau partenaire à Lille Toosla annonce un nouveau partenariat pour lancer la location de voiture à Lille, troisième gare nationale et zone frontalière. Ouverture des réservations dès aujourd'hui Partenariat DIGITAL Toosla Location De Voiture Lille
PRESS RELEASE published on 10/23/2024 at 17:55, 1 year 10 months ago Activité du 3ème trimestre 2024 : +37% de revenus et +139% de prise de commandes Exail Technologies affiche une croissance notable au 3ème trimestre 2024, avec un chiffre d'affaires de 89 M€, en hausse de +37%, grâce à des commandes importantes en navigation et robotique maritime Croissance Prise De Commandes Navigation Exail Technologies Robotique Maritime
PRESS RELEASE published on 10/23/2024 at 17:55, 1 year 10 months ago Activity of the 3rd quarter 2024: +37% revenue and +139% order intake Exail Technologies achieved record-breaking third-quarter results with a 37% revenue growth reaching €89 million. Strong order intake of €144 million, particularly in maritime robotics and navigation systems for civil and defense. Company secures part of annual objectives ahead of schedule Revenue Growth Order Intake Record-breaking Exail Technologies Maritime Robotics
PRESS RELEASE published on 10/23/2024 at 17:50, 1 year 10 months ago Konkur annonce la finalisation d'un accord conditionnel pour la vente de toutes ses actions détenues dans AgroGeneration Konkur Investments Limited vend ses actions d'AgroGeneration à NOVAAGRO, entreprise ukrainienne, conditions de la transaction remplies malgré les difficultés post-invasion russe en Ukraine Transaction AgroGeneration Ukraine NOVAAGRO Konkur Investments Limited
PRESS RELEASE published on 10/23/2024 at 17:50, 1 year 10 months ago Chiffre d'affaires du troisième trimestre 2024 : Accélération de la croissance organique (+4,3% sur 3 mois et +0,7% sur 9 mois) Aubay affiche une croissance organique de 4,3% au T3 2024, portée par la France et l'international. Objectif CA annuel entre 534M€ et 550M€ Croissance Organique International Objectifs Financiers France Aubay
Published on 09/15/2026 at 05:00, 15 minutes ago Lobe Sciences to Present Low-Dose L-130 Clinical Data at 9th Neuropsychiatric Drug Development Summit
Published on 09/15/2026 at 04:00, 1 hour 15 minutes ago Storm Closes Oversubscribed $3.2M Private Placement
Published on 09/15/2026 at 02:50, 2 hours 25 minutes ago RJK Explorations Ltd. Announces Closing of Previously Upsized Private Placement for Gross Proceeds of $150,000
Published on 09/14/2026 at 23:00, 6 hours 15 minutes ago AI/ML Innovations Inc. Closes Final Tranche of Private Placement
Published on 09/15/2026 at 05:00, 14 minutes ago China's development philosophy resonates across Global South at BRICS Summit
Published on 09/15/2026 at 04:15, 59 minutes ago Taiwan Leads 12 Startups to IFA Berlin 2026, Sealing Multiple Taiwan-Europe Deals
Published on 09/15/2026 at 02:15, 2 hours 59 minutes ago Shanghai Electric Reports 16.6% Revenue Growth in H1 2026 as New Orders Reach CNY 100.39 Billion
Published on 09/14/2026 at 20:42, 8 hours 32 minutes ago WashTec accelerates its transformation into a solutions and services provider and streamlines its management structure
Published on 09/14/2026 at 20:05, 9 hours 9 minutes ago NNS launches voluntary all-cash offer for OCI Shares
Published on 09/14/2026 at 18:21, 10 hours 53 minutes ago Reporting on share buyback transactions carried out between September 7 and September 10, 2026
Published on 09/14/2026 at 18:21, 10 hours 53 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 7 et le 10 septembre 2026
Published on 09/14/2026 at 18:00, 11 hours 15 minutes ago Mint franchit une nouvelle étape de sa transformation BtoB : deux signatures majeures viennent conforter une stratégie de croissance récurrente en accélération
Published on 09/14/2026 at 17:45, 11 hours 30 minutes ago Déclaration hebdomadaire de rachat d'actions